NTLA
Intellia TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
NTLA vs peer average
41/100
NTLA vs. peer average (D vs. C)
Grade spread
B 2 · C 4 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
OMER is the first available peer comparator.
Useful mainly as a small-cap biotech balance-sheet and execution-risk context comp; read-through on modality and indication remains limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NTLA
Intellia Therapeutics
OMER
Omeros
Grade
D
D
Momentum
17
35
Value
41
41
Sentiment
65
61
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs OMER
NTLA / OMER
Grade Position
Below peers
NTLA vs. peer average (D vs. C)
41/100
Momentum
17
OMERValue
41
NTLASentiment
65
NTLARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NTLA
OMER is the first peer returned for this comparison set.